agonists and antagonists identified both µ-and δ-opioid receptors as regulators of sperm kinematics, wherein µ maintains or increases sperm movement whereas δ decreases sperm motility over time.
Introduction
Exogenous opioids (opiate-like) are widely used in human and veterinary medicine to treat moderate to severe pain, but can become addictive (World Drug Report 2015) .
Endogenous opioid peptides (endorphins, enkephalins, dynorphins, etc) can inhibit the transmission of pain as well as participate in the regulation of reproductive function through the central nervous system (Kiani et al., 2009) , inhibiting the release of gonadotropinreleasing hormone and thus blocking the release of luteinizing hormone and/or folliclestimulating hormone from the hypophysis (Fabbri et al., 1989 ).
Opioids of exogenous or endogenous nature bind to members of the transmembrane G protein coupled receptors superfamily: the μ-, δ-, and κ-opioid receptors. These receptors inhibit adenyl cyclase, which suppresses the opening of voltage-gated calcium channels while facilitating opening of potassium channels, leading to cell hyperpolarization and cell-specific responses (Ong and Cahill, 2014) . A variety of signal transduction pathways are induced after receptor activation, including activation of the mitogen-activated protein (MAP) kinases and phospholipase C-controlled cascades (Ong and Cahill, 2014) . In human spermatozoa, for example, opioid receptor activation facilitates the acrosome reaction via protein kinase C signaling (Urizar-Arenaza et al., 2015) .
Exogenous opioids -such as morphine, heroine, or methadone -can negatively affect human reproductive function. In females, these opioids apparently impair estrogen receptor activity (Kornyei et al., 1999; Shuey et al., 2007; Lee and Ho, 2013) . In males, exogenous opioids decrease serum levels of luteinizing hormone and testosterone, leading to dysfunctional copulatory behavior (Pfaus and Gorzalka, 1987; Tokunaga et al., 1977) , decreased libido, and erectile dysfunction (Succu et al., 2006; Hallinan et al., 2008) . They also reduce the size of accessory glands and sperm production (James et al., 1980; Da Silva et al., 2006) , as manifested by lower ejaculate volume, fewer spermatozoa, and decreased sperm motility (Ragni et al., 1985) , deviant sperm morphology (el-Gothamy and el Samahy, 1992) , and decreased integrity of the genomic sperm DNA (Safarinejad et al., 2012) .
Endogenous ß-endorphins are released from the anterior pituitary in relation to pain or stress, and are secreted by genital epithelial cells: those produced by granulosa cells (Kaminski et al., 2000) are found in follicular fluid (Petraglia et al., 1986) ; those produced by human or bovine oviductal or endometrial cells end up in tubal and uterine fluids (Petraglia et al., 1986) ; and those produced by the accessory sexual glands reside in the seminal plasma (Fujisawa et al., 1996; Subirán et al., 2008) . Cells in contact with these fluids, such as oocytes (Agirregoitia et al., 2012a) or somatic epithelial or muscle cells of the genital organs (Petraglia et al., 1986; Desantis et al., 2008) , contain opioid receptors -particularly of the μ-and δ-type, which exhibit the highest affinity for ß-endorphin (Minoia and Sciorci, 2001) - suggesting that these endogenous endorphins are paracrine regulators of reproductive function (Fabbri et al., 1989) . Indeed, ß-endorphins and enkephalins present in human seminal plasma can associate with ejaculated spermatozoa (Subirán et al., 2008; Subirán et al., 2012) . This interaction has been indirectly ascribed a role in sperm motility, based on the observation that opioid analgesics commonly used at the hospitals reduce sperm motility (Xu et al., 2012) . A minimum concentration of opioid peptides in seminal plasma was experimentally determined to be necessary to maintain human sperm motility in vitro (Fujisawa et al., 1996) .
The receptors targeted by both exogenous and endogenous opioids reside on a plethora of somatic cells in the pituitary, pineal gland, gastrointestinal tract, liver, pancreas, kidney, skin (reviewed by Desantis et al., 2008 ), cumulus-oophorus (Dell´Aquila et al., 2002 , and oviductal isthmus (Desantis et al., 2008) . Opioid receptors are present on spermatozoa, although the current -albeit not comprehensive-experimental evidence suggests their presence is not ubiquitous; indeed, positive evidence is limited to human (μ- [Agirregoitia et al., 2006; Albrizio et al., 2006 ], δ-and κ- [Agirregoitia et al., 2006] ), equine (μ- [Albrizio et al., 2005 ] and δ- [Albrizio et al., 2010] ), sea bream (µ-, Albrizio et al., 2013) , and ovine (Vicente-Carrillo et al., 2015a) . These opioid receptors are reported to mediate sperm motility in humans (Agirregoitia et al., 2006; 2012b) and equine (Albrizio et al., 2005; Albrizio et al., 2010) , although results are contradictory regarding the effects of opioid antagonists. For instance, antagonists of the δ-opioid receptor increase motility of stallion spermatozoa (Albrizio et al., 2010) but decrease human sperm motility (Agirregoitia et al., 2006; 2012b) .
Determining if these differences are due to species differences requires further research.
Boar spermatozoa are valuable for pharmacological and toxicological in vitro testing (Vicente-Carrillo et al., 2015b) . This study was undertaken to address (i) the presence and distribution of μ-, δ-, and κ-opioid receptors in these gametes and (ii) their relation to in vitro sperm kinematics, sperm viability, mitochondrial integrity, and early membrane 
Results

Boar spermatozoa express only μ-and δ-opioid receptors
Western blots established the presence of the µ-and δ-opioid receptors in ejaculated pig spermatozoa, revealing a protein of 45 kDa for the µ-opioid receptor and 70 kDa for the δ-opioid receptor; the κ-opioid receptor was not detected (Fig. 1) . Immunocytochemistry further showed that both µ-and δ-opioid receptors reside over the plasma membrane covering the acrosome, the neck, and the principal piece of pig spermatozoa (µ-opioid receptor, Fig 2E; δ-opioid receptor, 2F); again, κ-opioid receptor was not detectable (Fig 2G) .
Human spermatozoa, used as a positive control, contained each of these opioid receptors, as seen by Western blot (Fig. 1) and immunocytochemistry ( Fig. 2A-2C ).
Immunocytochemical controls where the primary antibody was omitted appeared negative (human sperm, Fig 2D; pig sperm, Fig 2H) , supporting the specificity of the staining.
The μ-opioid receptor modulates boar sperm motility
Under baseline conditions, total and progressive sperm motility, but not sperm velocity, were affected by time with a significant (P<0.05) reduction after 30 min (Table 1 ). Exposure to 1 or 10 µM morphine abolished this time-dependent effect, significantly increasing total and progressive sperm motility for as long as 60 min (Table 1 ). The µ-antagonist naloxone, at 1 and 100 µM, significantly reduced sperm motility over time (Table 1) .
No apparent time-effect changes were observed in sperm viability, mitochondria integrity, or stability of the plasma membrane among control samples. Incubation with 0.1 and 1 µM of morphine, however, led to a significant (P<0.05) reduction of sperm viability and mitochondrial integrity over time, while 10 µM of morphine only reduced mitochondrial integrity (Table 1) . Incubation with naloxone, on the other hand, did not affect any of the flow-cytometry variables monitored compared to controls or elapsed time ( Table 1 ).
The δ-opioid receptor does not mediate sperm motility
Exposure to 0.1 µM of DPDPE lead to a significant reduction in sperm motility over time (P<0.05) compared to the control conditions; conversely, no other concentrations of DPDPE or any concentrations of naltrindole affected sperm motility (Table 2) . Sperm viability and mitochondrial integrity of controls were the only measures significantly reduced over time (p<0.05 after 30 min, Table 2 ). The highest concentration of naltrindole tested (100 µM) caused a significant decrease (P<0.05) in sperm viability after 60 min (Table 2) .
κ-opioid receptor agonists and antagonists appear to be toxic to pig sperm
Total and progressive sperm motility, sperm velocity, sperm viability, and mitochondrial integrity were time-affected in the control, with a significant (P<0.05) reduction after 30 min (Table 3) . Exposure to 0.1 and 1 µM U 50488 or 10 and 100 µM nor-binaltrorphimine did not cause any significant change in time-effect compared to the control; further, 10 µM U 50488 and 1 µM nor-binaltrorphimine maintained sperm kinematics over time (Table 3 ).
Both 0.1 and 10 µM U 50488 significantly decreased sperm velocity compared to the control at 15 min incubation (Table 3 ). The highest concentration of nor-binaltrorphimine tested (100 µM) caused a significant (P<0.05) decrease in sperm velocity compared to the control at 10, 15, and 30 min time points (Table 3) . By 60 min incubation, 100 µM nor-binaltrorphimine caused a significant increase in early membrane destabilization and a reduction in sperm viability compared to the control (Table 3) .
Discussion
The μ-and δ-opioid receptors, but not the κ-opioid receptor, were hereby identified in ejaculated boar spermatozoa by WB and ICC. Both μ-and δ-receptors shared the same membrane location over the plasma membrane (acrosome, neck and principal piece domains) confirming that sperm-expressed opioid receptors appear to be unmodified among the species that utilize them. The μ-opioid receptor migrates as 65-70 and 50 kDa bands in human spermatozoa (Agirregoitia et al., 2006 , Albrizio et al., 2006 ; 50 and 65 kDa in equine spermatozoa (Albrizio et al., 2005) ; and 45 kDa in boar spermatozoa. The δ-opioid receptor is 50 kDa in human spermatozoa (Agirregoitia et al., 2006) ; migrates as 50 and 65 kDa in equine spermatozoa (Albrizio et al., 2010) ; and is 70 kDa in boar spermatozoa. The κ-opioid receptor was detected as four different bands of 100, 65, 56, and 36.5 kDa in human spermatozoa (Agirregoitia et al., 2006) ; the commercially available antibodies raised against the κ-opioid receptor failed to detect this subtype in boar spermatozoa, suggesting that it is not abundant or present in these gametes.
The distribution of sperm μ-and δ-opioid membrane receptors appears to be conserved among animals that express it. The human μ-opioid receptor resides in the plasma membrane of the sperm head, at the equatorial and post-acrosomal region, in part of the midpiece, and in the tail (Agirregoitia et al., 2006) or over the acrosomal region of the sperm head and on the neck (Albrizio et al., 2006) . In equine spermatozoa, the μ-opioid receptor is similarly found over the membrane of the acrosome and the tail (Albrizio et al., 2005) . In sea bream spermatozoa, the µ-opioid receptor was detected over the head (Albrizio et al., 2013) . In boar spermatozoa, both μ-and δ-receptors can be found at the plasma membrane over the acrosome, neck, and principal piece. The δ-opioid receptor is more restricted than the µ-opioid receptor in stallion sperm -primarily over the tail (Albrizio et al., 2010) -and in human spermatozoa -limited to the acrosome region, the mid-piece, and uniformly distributed along the tail (Agirregoitia et al., 2006) . Finally, the κ-opioid receptor can be found in the sperm head, the mid-piece, and the tail of human spermatozoa (Agirregoitia et al., 2006 and nor-binaltrorphimine [κ]) used in human or veterinary medicine. We included analysis of κ-opioid receptor pharmacological modulators because sub-detectable levels of the receptor may still be active and contribute to sperm physiology. The range of drug concentrations evaluated were informed by previously work performed on human spermatozoa (Agirregoitia et al., 2006) , whereas the challenge intervals were shorter in order to minimize toxic timedependent effects that commonly occur when working with spermatozoa (unpublished).
Morphine-challenge in boar spermatozoa followed a classic biphasic, dose-dependent effect of opioids (Feigenbaum and Howard, 1997) , with an immediate decrease in sperm motility and a posterior inversion of effects by 60 min of incubation (P<0.05). These results agree with previous observations in equine spermatozoa (Albrizio et al., 2005) , but are clearly different from findings in human, in which morphine seems to inhibit sperm motility after 3 h (Agirregoitia et al., 2012b) . These differences indicate that the function of µ-opioid receptor is not completely shared among species and the roles it plays are sensitive to exposure time. DPDPE, the δ-opioid receptor agonist, induced a decrease in boar sperm motility over time at 0.1 µM, yet no effect was observed from the other DPDPE concentrations or using the δ-antagonist naltrindole. This clearly differs from findings in the stallion, in which naltrindole increased sperm motility at low concentrations but decreased it at high concentrations (Albrizio et al., 2010) . On the other hand, naltrindole decreases human sperm motility (Agirregoitia et al., 2012b) . Such extreme differences with the δ-opioid receptor among species warrant further studies using ß-endorphins and met-enkephalins.
Exposure of boar spermatozoa to the κ-opioid agonist U 50488 and its antagonist norbinaltrorphimine did not elicit changes in any of the viable sperm kinematics studied; however, both were toxic at higher concentrations. These negative findings generally support the absence of the receptor in these spermatozoa -particularly since the toxicity observed in vitro might be associated with off-target effects, such as affecting other opioid receptors than the κ-opioid receptor. These data are also consistent with those from human spermatozoa challenged with κ-opioid agonist and antagonist, which had no effect. In this regard, the κ-opioid receptor does not appear to contribute to the regulation of sperm motility in men; alternatively, observing its activity requires longer exposure conditions or drug levels (Agirregoitia et al. 2006; Agirregoitia et al., 2012b) . Interestingly, the κ-opioid receptor is found on granulosa cells of growing porcine ovarian follicles (Słomczyńska et al., 1997) , suggesting that its function may be gender specific. Understanding these negative sperm data in light of possible gender differences is warranted.
The initial contribution of endogenous opioids to fertility were thought to be minor based on reports that administration of exogenous opiates (Pfaus and Gorzalka, 1987; Succu et al., 2006) does not result in infertility (Miralles-García et al., 1986) or reduction in sperm motility (Davidson et al., 1989 ) -although this absence of an effect associated with the need of long-exposure of the opiates (Hallinan et al., 2008; Vuong et al., 2010) . This perspective was questioned by reports that opioid analgesics impair human sperm motility (Xu et al., 2012) , as well as the observed changes to ß-endorphin levels in the peripheral blood of stressed sows (Einarsson et al., 2008) or experimentally induced sexual frustration in boars (Bishop et al., 1999) .
Natural variation in opiate levels during the estrous cycle implies that these molecules do participate in female reproductive function. Indeed, concentrations of endorphins and enkephalins in follicular fluid peak pre-ovulation (Kaminski et al., 2000) while ß-endorphins vary in coordination with uterine and oviductal contractions induced by oestradiol, which also peak during the peri-ovulatory period (Okrasa et al., 2003) . Granulosa cells change steroidogenesis pathway in pigs in response to ß-endorphins (Kaminski et al., 2004) , possibly acting in a feedback loop. The µ-opioid receptor is also present in the oviduct segment where capacitation takes place (Desantis et al., 2008) , as well as in the myometrium and the myosalpinx, which respond to ß-endorphins via µ-receptors (Desantis et al., 2008) , resulting in contractions that are pivotal for sperm transport (Rodriguez-Martinez et al., 2005) .
The relationship between opioid receptor activity and the female reproductive organs -in combination with the observations that sperm exposure to µ-opioid receptor agonists enhances total and progressive sperm motility in boar, using the potent µ-agonist morphine (Satoh and Minami, 1995) , and in humans, when met-enkephalin, a weaker µ-agonist (Leslie 1987) , was used (Subirán et al., 2012 ) -supports a model in which opioid receptors participate in sperm transport, particularly during in vivo sperm storage, capacitation, and interaction with the cumulus-oophorus complex: Spermatozoa colonize sperm reservoirs in the lower oviduct, progressing towards the upper segments to encounter the newly ovulated oocytes in coordination with ovulation (Rodriguez-Martinez, 2007) . Changes in motility occur when spermatozoa separate from the tubal epithelium, and stronger beating is required for penetration of the cumulus-oophorus and particularly, of the zona pellucida (Gadella and Luna, 2014) . Opioid receptors are present in ciliated tubal cells (Desantis et al., 2008) , and may specifically regulate ciliary beating, as reported for other organs (Roth et al., 1991) ; whether or not the sperm tail, with its flagellar core, may act similarly remains to be tested.
The sources of the cellular activity that fosters sperm progression towards an oocyte include calcium and ATP. The oviduct fluid contains Ca 2+ (Cox and Leese, 1997) , which maintains the ciliary beating that establishes the directed fluid flow. Ca 2+ influx also occurs during boar sperm capacitation via specific calcium channels, including CatSper channels (unpublished), as well as through opioid ligand-receptor interaction -albeit the latter effects decrease sperm motility (Minoia and Sciorci, 2001) . ATP production may also be affected by opiates, as observed in somatic cells (Sciorci et al., 2000) . Exposure of boar spermatozoa to the µ-agonist morphine reduces mitochondrial function, despite the maintained or elevated sperm motility. At face value, this would be a paradox; yet boar spermatozoa consume an abundance of glucose through glycolysis and respiratory oxidation (Rodriguez-Gil and Bonet, 2016) , so decreased mitochondrial integrity might not lead to an immediate energy deficit.
Finally, boar spermatozoa can be used to detect drug-induced toxicity using kinematics as 
Material and Methods
Experimental design
Ejaculated, commercially extended boar spermatozoa were examined for the presence and distribution of μ-, δ-, and κ-opioid receptors using Western blot and immunocytochemistry, 
Animals and sperm collection
Mature Swedish Hampshire breeding boars, selected according to normal semen quality and proven fertility, were housed individually on straw beds at Quality Genetics (now Svenska Köttföretagen, SvKF, Hållsta, Sweden). The animals were fed with commercial rations (Läntmännen, Stockholm, Sweden) according to national standards (Simonsson, 1994) , and provided with water ad libitum.
The sperm-rich fraction of the ejaculate was manually collected twice weekly using the gloved-hand method. Sperm-rich fractions from three boars were pooled, extended in either 
Immunocytochemistry
Spermatozoa were fixed in 4% paraformaldehyde at room temperature for 20 min. Cell suspensions were then centrifuged at 1,200 x g for 6 min, and the pellet was resuspended in PBS, pH 7.3 to prepare smears on poly-L-lysine slides (LSM, Thermo Scientific, Germany).
The smears were allowed to dry, washed three times for 5 min each with PBS, and blocked with 5% BSA in PBS at 4˚C for 120 min. After three washes in PBS for 5 min each, the slides were incubated at 4˚C overnight with primary antibodies diluted in 1% BSA-PBS: μ- The compound-sperm mixtures were placed on a shaking plate inside an incubator at 38˚C, and aliquots taken at 5, 10, 15, 30, and 60 min. Two aliquots were taken per time point:
25 µL for flow cytometry analyses of membrane and mitochondrial integrity and for signs of early membrane destabilization and a 10 µL for sperm kinematics analysis. 
Sperm kinematic analysis
Sperm motility, progressive motility, and sperm velocity were assessed using the spermatozoa/field, and has been validated for several species, including porcine (Tejerina et al., 2008; Rodriguez-Martinez et al 2008; Johannisson et al., 2009; Siqueira et al., 2011; Vicente-Carrillo et al., 2015) .
Statistics
The results obtained by challenging boar spermatozoa with opioid receptor agonists and antagonists were tested for normality with the Shapiro-Wilk test, and analyzed by one-way analysis of variance (ANOVA) using IBM SPSS Statistics 23 (IBM Corporation, Armonk, NY, USA) to compare the effect of the different concentrations (dose-response analysis) and the effect of the different incubation times (time-effect analysis). An independent samples ttest was applied to determine when the differences observed became significant at P<0.05. 
